Showing results (201-210 of 322) with videos related to
Sort By:
Pageof 33
The Journal of Infectious Diseases|August 1, 1990
Response to tetanus toxoid immunization after allogeneic bone marrow transplantationP Ljungman, M Wiklund-Hammarsten, V Duraj, et al.Bone Marrow Transplantation|March 8, 2005
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMTP Ljungman, D Engelhard, R de la Cámara, et al.Blood|May 1, 1994
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation GroupO Ringdén, T Ruutu, M Remberger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic factors in allogeneic bone marrow transplantation for multiple myelomaG Gahrton, S Tura, P Ljungman, et al.Acta Oncologica (Stockholm, Sweden)|May 5, 1999
FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study GroupH Lindman, T Wiklund, H Holte, et al.Bone Marrow Transplantation|August 10, 2004
Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host diseaseP Ljungman, J Aschan, L Barkholt, et al.The New England Journal of Medicine|October 31, 1991
Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow TransplantationG Gahrton, S Tura, P Ljungman, et al.Leukemia|July 26, 2012
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantationD Mougiakakos, R Jitschin, L von Bahr, et al.Bone Marrow Transplantation|March 1, 1991
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipientsO Ringdén, P Pihlstedt, L Markling, et al.European Journal of Haematology|February 13, 2001
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantationM Remberger, J Aschan, B Lönnqvist, et al.Pageof 33